GetTopicDetailResponse(id=a900550641d, topicName=抗CD40單抗, introduction=抗CD40單抗, content=null, image=null, comments=1, allHits=874, url=https://h5.medsci.cn/topic?id=55064, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=90856, tagList=[TagDto(tagId=90856, tagName=抗CD40單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2078645, encodeId=fbfa20e8645da, content=<a href='/topic/show?id=a900550641d' target=_blank style='color:#2F92EE;'>#抗CD40單抗#</a>, objectTitle=2019 ATC：諾華的抗CD40單抗iscalimab可提高腎移植的耐受性并改善長期預(yù)后, objectType=article, longId=168059, objectId=552b1680597c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=552b1680597c, replyNumber=0, likeNumber=96, createdTime=2019-08-20, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=552b1680597c, moduleTitle=2019 ATC：諾華的抗CD40單抗iscalimab可提高腎移植的耐受性并改善長期預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=552b1680597c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
